PubMed Health⌕ Search

Biomedical subjects

L Hyde

Publications and source records attributed to L Hyde.

28 records · Page 2Linked to original sources
PubMed1972

Rifampin in the treatment of pulmonary tuberculosis.

Rifampin is a newer semi-synthetic derivative of rifamycin. Its advantages over other derivatives are good oral absorption, high blood levels, and slower excretion rate. Rifampin has been studied in 68 patients and results can be summarized as follows:* There has been no evidence of significant toxicity.* In a randomized study of active tuberculosis patients who had not received prior chemotherapy, isoniazid-rifampin and isoniazid-aminosalicylic acid regiments were equally effective.* In retreatment patients with active, positive tuberculosis, the regimen of isoniazid, rifampin, and ethambutol proved to be very effective, especially when the two latter drugs had not been used previously.* In patients with pulmonary infections caused by atypical acid-fast bacilli, results varied with the organism isolated and the extent of disease. Rifampin is a potent, relatively non-toxic drug especially useful in the retreatment of pulmonary tuberculosis in patients who have never received this drug previously. There is little justification for its use in initial therapy except in rare cases.

Aminosalicylic Acids↗
PubMed1965

Lung cancer and month of birth.

A statistical study of possible relationship of month of birth to the occurrence of lung cancer was carried out at Veterans Administration Hospital, Long Beach. The distribution of the 200 lung cancer cases by month of birth did not differ significantly from that which might be expected by chance alone. These findings do not substantiate those found by Dijkstra in The Netherlands.

Clinical Trials as Topic↗